A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer
A Phase 1 Trial of SHR3680 With or Without SHR3162 in Subjects With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Atridia Pty Ltd.
Listed as NCT02747342, this PHASE1 trial focuses on Neoplasm and Prostate Cancer and remains completed. Sponsored by Atridia Pty Ltd., it has been updated 15 times since 2016, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Aug 2020 — Jan 2021 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Feb 2020 — Aug 2020 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
▶ Show 10 earlier versions
-
Jan 2020 — Feb 2020 [monthly]
Recruiting PHASE1
-
Jul 2019 — Jan 2020 [monthly]
Recruiting PHASE1
Status: Active Not Recruiting → Recruiting
-
Mar 2019 — Jul 2019 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Jan 2019 — Mar 2019 [monthly]
Recruiting PHASE1
-
Oct 2018 — Jan 2019 [monthly]
Recruiting PHASE1
-
Jun 2018 — Oct 2018 [monthly]
Recruiting PHASE1
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE1
-
Jun 2017 — Dec 2017 [monthly]
Recruiting PHASE1
-
May 2017 — Jun 2017 [monthly]
Recruiting PHASE1
-
Jan 2017 — May 2017 [monthly]
Recruiting PHASE1
First recorded
Sep 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Atridia Pty Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .